Sani, G.; Margoni, S.; Brugnami, A.; Ferrara, O.M.; Bernardi, E.; Simonetti, A.; Monti, L.; Mazza, M.; Janiri, D.; Moccia, L.;
et al. The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies. Antioxidants 2023, 12, 817.
https://doi.org/10.3390/antiox12040817
AMA Style
Sani G, Margoni S, Brugnami A, Ferrara OM, Bernardi E, Simonetti A, Monti L, Mazza M, Janiri D, Moccia L,
et al. The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies. Antioxidants. 2023; 12(4):817.
https://doi.org/10.3390/antiox12040817
Chicago/Turabian Style
Sani, Gabriele, Stella Margoni, Andrea Brugnami, Ottavia Marianna Ferrara, Evelina Bernardi, Alessio Simonetti, Laura Monti, Marianna Mazza, Delfina Janiri, Lorenzo Moccia,
and et al. 2023. "The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies" Antioxidants 12, no. 4: 817.
https://doi.org/10.3390/antiox12040817
APA Style
Sani, G., Margoni, S., Brugnami, A., Ferrara, O. M., Bernardi, E., Simonetti, A., Monti, L., Mazza, M., Janiri, D., Moccia, L., Kotzalidis, G. D., Chieffo, D. P. R., & Janiri, L.
(2023). The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies. Antioxidants, 12(4), 817.
https://doi.org/10.3390/antiox12040817